Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Rani Therapeutics Holdings (RANI) over the last 4 years, with Q2 2025 value amounting to $5.8 million.

  • Rani Therapeutics Holdings' Change in Acquisitions & Divestments fell 6840.66% to $5.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was $47.0 million, marking a year-over-year decrease of 4126.09%. This contributed to the annual value of $77.6 million for FY2024, which is 2568.28% down from last year.
  • According to the latest figures from Q2 2025, Rani Therapeutics Holdings' Change in Acquisitions & Divestments is $5.8 million, which was down 6840.66% from $21.0 million recorded in Q1 2025.
  • Rani Therapeutics Holdings' 5-year Change in Acquisitions & Divestments high stood at $35.0 million for Q2 2023, and its period low was $3.0 million during Q4 2022.
  • In the last 4 years, Rani Therapeutics Holdings' Change in Acquisitions & Divestments had a median value of $20.3 million in 2024 and averaged $19.2 million.
  • As far as peak fluctuations go, Rani Therapeutics Holdings' Change in Acquisitions & Divestments soared by 66166.67% in 2023, and later crashed by 6840.66% in 2025.
  • Quarter analysis of 4 years shows Rani Therapeutics Holdings' Change in Acquisitions & Divestments stood at $3.0 million in 2022, then surged by 661.67% to $22.8 million in 2023, then decreased by 11.16% to $20.3 million in 2024, then plummeted by 71.67% to $5.8 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $5.8 million for Q2 2025, versus $21.0 million for Q1 2025 and $20.3 million for Q4 2024.